GeorgeMarzloffMD

PubMed

• The presence or absence of midsagittal tissue bridges and walking: a retrospective cohort study in spinal cord injury.
  W A Thornton, G Marzloff, S Ryder, A Best, K Rasheed, D Coons, A C Smith> ;Spinal Cord. 2023 Aug 1
• Emerging Technologies in the Wound Management Field.
  George Marzloff, Stephanie Ryder, Jennifer Hutton, Kaila Ott, Mallory Becker, Scott Schubert> ;Physical Medicine and Rehabilitation Clinics of North America. 2022 Nov 1
• 1 citations
  Wheelchair Mobility-Related Injuries Due to Inadvertent Lower Extremity Displacement on Footplates: Analysis of the FDA MAUDE Database From 2014 to 2018.
  Maureen Whitford, Steven J. Mitchell, George E Marzloff, Jennifer K Zindle, Mary Ann Richmond, Kath M. Bogie, M Kristi Henzel> ;Journal of Patient Safety. 2021 Dec 1
• 1 citations
  Establishing a Comprehensive Wound Care Team and Program.
  Scott Schubert, George Marzloff, Stephanie Ryder, Kaila Ott, Jennifer Hutton, Mallory Becker> ;Physical Medicine and Rehabilitation Clinics of North America. 2022 Nov 1
• Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.
  Palmqvist S, Zetterberg H, Mattsson N, Johansson P, Minthon L, Blennow K, Olsson M, Hansson O> ;Neurology. 2015 Oct 6
• Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
  Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust WJ, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM> ;Neurology. 2015 Feb 17
• Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.
  Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Scholl M, Choo IH, Grimmer T, ...> ;Neurology. 2015 Feb 3
• 26 citations
  Predicting missing biomarker data in a longitudinal study of Alzheimer disease
  Raymond Y. Lo, William J. Jagust, Paul S. Aisen, Clifford R. Jack, Arthur W. Toga, Laurel A. Beckett, Anthony Gamst, Holly Soares, Robert C. Green, T. J. Montine, Rona...> ;Neurology. 2012 May 1
• Predicting MCI outcome with clinically available MRI and CSF biomarkers.
  Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK> ;Neurology. 2011 Oct 25
• Longitudinal change of biomarkers in cognitive decline.
  Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ> ;Arch Neurol. 2011 Oct
• Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
  Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW,...> ;Neurology. 2011 Jan 4
• Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach.
  Vounou M, Nichols TE, Montana G> ;Neuroimage. 2010 Nov 15
• Voxelwise genome-wide association study (vGWAS).
  Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Pot...> ;Neuroimage. 2010 Nov 15
• Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.
  Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR Jr, Weine...> ;Neuroimage. 2010 Nov 15
• Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease.
  Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T> ;Neuroreport. 2010 Aug 23
• Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.
  Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC> ;Neurobiol Aging. 2010 Aug
• Multi-modal imaging predicts memory performance in normal aging and cognitive decline.
  Walhovd KB, Fjell AM, Dale AM, McEvoy LK, Brewer J, Karow DS, Salmon DP, Fennema-Notestine C> ;Neurobiol Aging. 2010 Jul
• A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T).
  Keihaninejad S, Heckemann RA, Fagiolo G, Symms MR, Hajnal JV, Hammers A> ;Neuroimage. 2010 May 1
• 166 citations
  Subregional neuroanatomical change as a biomarker for Alzheimer's disease
  Dominic Holland, James B. Brewer, Donald J. Hagler, Christine Fennema-Notestine, Anders M. Dale, Michael W. Weiner, Leon J. Thal, Ronald C. Petersen, Clifford R. Jack,...> ;Proceedings of the National Academy of Sciences of the United States of America. 2009 Dec 8
• 29 citations
  Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brains of weanling pups.
  Mehmet Cansev, George Marzloff, Toshimasa Sakamoto, Ismail H. Ulus, Richard J. Wurtman> ;Developmental Neuroscience. 2009 Jan 15
• High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
  Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ> ;JAMA. 2008 Oct 15
• 127 citations
  Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally
  Richard J. Wurtman, Ismail H. Ulus, Mehmet Cansev, Carol Watkins, Lei Wang, George Marzloff> ;Brain Research. 2006 May 9
• Join now to see all

Abstracts/Posters

• Sensory ataxia, weakness, and hyperreflexia in a patient with neurofibromatosis type 1: a case report
  George Marzloff MD, Mariam Zakhary DO, Elizabeth Adamov, DO, Subhadra Nori, MD, AAP Annual Meeting 2017, Las Vegas, NV, 2/9/2017
• Nonsystemic vasculitic neuropathy misdiagnosed as acute motor and sensory axonal neuropathy- a case report
  George Marzloff, Ajax Yang, and Anne Felicia Ambrose, AAP Annual Meeting 2016, Sacramento, CA, 2/18/2016
• Laser treatment of trismus after gunshot wound to face: a case report
  Arpit Patel, George Marzloff, and Lyn Weis, AAPM&R Annual Assembly, San Diego, CA, 11/2014
• NIC5-15 as a treatment for Alzheimer's: Safety, pharmacokinetics, and clinical variables
  Hillel Grossman, George Marzloff, Xiaodong Luo, Derek LeRoith, Mary Sano, and Giulio Pasinetti, International Conference for Alzheimer's Disease, Vienna, Austria, 7/2009
• Uridine plus docosahexaenoic acid increase phospholipids and synaptic proteins in brains of developing rat pups
  George Marzloff, Mehmet Cansev, and Richard J. Wurtman, Neuroscience 2006, Atlanta, GA, 10/2006
• Mehmet Cansev, Richard Wurtman, Ismail H. Ulus, Carol Watkins, Lei Wang, George Marzloff and Toshimasa Sakamoto
  Characterization of polyunsaturated fatty acids that affect synaptic proteins and phospholipids in gerbil brain, Neuroscience 2006, Atlanta, GA, 10/2006
• Synaptic phospholipids and proteins are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally
  Richard Wurtman, Ismail H. Ulus, Mehmet Cansev, Carol Watkins, Lei Wang and George Marzloff, Experimental Biology 2006, San Francisco, CA, 4/2006
• Oral uridine (UMP) plus docosahexaenoic acid increases phospholipids and synaptic proteins in gerbil brain
  Mehmet Cansev, Richard Wurtman, Ismail H. Ulus, Carol Watkins, Lei Wang, and George Marzloff, International Society for Neurochemistry, Portland, OR, 3/2006
• The role of theory of mind in making inferences about novel objects.
  George Marzloff, Anne Chin and Joshua Tenenbaum, MIT Brain & Cognitive Sciences Undergraduate Research, Cambridge, MA, 4/2004
• Join now to see all